| Identification | Back Directory | [Name]
1,8-Naphthyridin-2(1H)-one, 5-[[(3S)-3-[5-(4-fluorophenyl)-1H-imidazol-2-yl]-3,4-dihydro-2H-1-benzopyran-6-yl]oxy]-3,4-dihydro- | [CAS]
2760321-00-2 | [Synonyms]
1,8-Naphthyridin-2(1H)-one, 5-[[(3S)-3-[5-(4-fluorophenyl)-1H-imidazol-2-yl]-3,4-dihydro-2H-1-benzopyran-6-yl]oxy]-3,4-dihydro- | [Molecular Formula]
C26H21FN4O3 | [MOL File]
2760321-00-2.mol | [Molecular Weight]
456.47 |
| Hazard Information | Back Directory | [Uses]
Flezurafenibum (Flezurafenib) is a rapidly accelerated fibrosarcoma (Raf) kinase inhibitor, with antineoplastic effect[1]. | [References]
[1] Flezurafenibum (Flezurafenib). WHO Drug Information, Vol. 37, No. 4, 2023. |
|
|